(1)
Umar, T. P.; Ramadhan, M. S.; Mahfuza, N. Urokinase Plasminogen Activator Receptor (uPAR) Targeted Therapy With Switchable Chimeric Antigen Receptor T-Cell (sCAR T-Cell) Potential As Pancreatic Cancer Immunotherapy Agent. Int. J. Hum. Health Sci. 2020, 5, 171-176.